Cefoperazone & Sulbactam For Inj.(2:1)

What is Cefoperazone & Sulbactam for Injection (2:1)?

Cefoperazone and Sulbactam for Injection (2:1) is a combination antibiotic formulation containing a cephalosporin antibiotic and a beta-lactamase inhibitor. It is intended for use by qualified healthcare professionals to treat selected bacterial infections when supported by approved product information and clinical assessment. Available strengths are 750mg, 1.5gm and 3gm.

Uses / Indications

This combination may be used for certain bacterial infections caused by susceptible organisms, depending on the approved product information and local treatment guidelines. Potential clinical applications may include:

• Selected respiratory tract infections

• Certain urinary tract infections

• Skin and soft-tissue infections

• Intra-abdominal infections

• Other susceptible bacterial infections as specified in the approved prescribing information

The precise indications depend on the product’s approved labelling, local guidance and the patient’s clinical condition.

Benefits

• Combines cefoperazone with sulbactam in one injectable formulation.

• Cefoperazone acts against susceptible bacteria by inhibiting bacterial cell-wall synthesis.

• Sulbactam inhibits certain beta-lactamase enzymes that can reduce the activity of some beta-lactam antibiotics.

• Offers multiple listed strengths for healthcare-professional-directed treatment, subject to approved product specifications.

Side Effects

Common or Possible Side Effects

• Diarrhoea or loose stools

• Nausea or vomiting

• Skin rash or itching

• Injection-site discomfort

• Changes in liver-function test results

Serious Side Effects

• Severe allergic reactions, including swelling of the face or throat or difficulty breathing

• Severe or persistent diarrhoea

• Unusual bruising or bleeding

• Severe skin reactions

Seek urgent medical care if a serious allergic reaction or other severe symptom occurs. The full adverse-effect profile should be checked against the approved product information for the specific formulation.

How Does It Work?

Cefoperazone is a cephalosporin antibiotic that interferes with bacterial cell-wall synthesis, leading to the death of susceptible bacteria. Sulbactam inhibits certain beta-lactamase enzymes produced by bacteria, helping protect susceptible beta-lactam antibiotics from enzymatic breakdown. The combination’s effectiveness depends on the organism involved and its susceptibility.

Dosage Guidelines

• The appropriate strength, dose, frequency and treatment duration must be determined by a qualified healthcare professional.

• Dosing depends on the infection, its severity, the patient’s age and clinical condition, and relevant organ function.

• Preparation, compatibility and administration must follow the approved product information.

• The listed strengths should not be treated as interchangeable dosing instructions.

The exact dose and treatment duration should follow the approved product information and the recommendation of a qualified healthcare professional.

When Not to Use

This product may not be appropriate for patients who:

• Have a known serious allergy to cefoperazone, sulbactam, cephalosporins or relevant beta-lactam antibiotics.

• Have a history of severe hypersensitivity reactions to related medicines, unless a qualified clinician determines that use is appropriate.

• Have another contraindication specified in the approved product information.

A healthcare professional should review the patient’s allergy history and medical conditions before treatment.

Drug / Product Interactions

Potential interactions or precautions may include:

• Anticoagulants and medicines affecting blood clotting: bleeding risk may increase in some patients.

• Alcohol: cefoperazone has been associated with alcohol-related reactions; follow the product’s approved warnings and professional advice.

• Other antibiotics or medicines: combined use should be assessed for clinical suitability and potential interactions.

Provide the treating healthcare professional with a complete list of prescription medicines, non-prescription products and supplements.

Safety Advice

• Use only under appropriate medical supervision.

• Inform the healthcare professional about previous antibiotic allergies, bleeding disorders and relevant liver or kidney conditions.

• Report unusual bruising, bleeding, persistent diarrhoea or signs of an allergic reaction promptly.

• Use antibiotics only for appropriate bacterial infections.

• Do not share the medicine or use leftover antibiotics without medical advice.

General Instructions

• The product should be prepared and administered by trained healthcare personnel.

• Follow the approved instructions for reconstitution, compatibility and administration.

• Inspect the vial and packaging before use; do not use damaged or questionable products.

• Do not use the product beyond its labelled expiry date.

• Follow the prescribed treatment plan and applicable infection-control procedures.

Special Dietary / Lifestyle Tips

• Follow the treating healthcare professional’s advice on diet and fluid intake.

• Ask whether alcohol should be avoided during treatment and for any specified period afterwards.

• Maintain adequate hydration unless medically restricted.

• Seek medical advice if diarrhoea or vomiting becomes persistent or interferes with fluid intake.

Comparison with Other Treatments

Cefoperazone and sulbactam combines an antibiotic with a beta-lactamase inhibitor. Other antibiotic combinations or single-agent antibiotics may be more appropriate depending on the infection, likely or confirmed pathogen, susceptibility results, allergy history and local treatment guidelines.

The combination should not be considered interchangeable with other injectable antibiotics solely because they share a therapeutic category.

Precautions & Warnings

• Allergy risk: Review previous reactions to cephalosporins, penicillins and other beta-lactam antibiotics.

• Bleeding risk: Particular assessment may be needed for patients with bleeding disorders or those taking anticoagulants.

• Liver and kidney function: Clinical assessment and monitoring may be appropriate in patients with relevant conditions.

• Antibiotic-associated diarrhoea: Severe or persistent diarrhoea requires prompt medical assessment.

• Pregnancy and breastfeeding: Use should be assessed by a healthcare professional according to the approved product information.

• Antimicrobial resistance: Use only when clinically indicated and in line with appropriate prescribing guidance.

Can I Use It With Other Medicines?

Cefoperazone and sulbactam may be used with other medicines when clinically indicated, but the combination should be reviewed by a qualified healthcare professional. Particular attention may be required for medicines affecting blood clotting and any other products identified in the approved interaction information. Do not start, stop or change medicines without professional advice.

Storage

Store according to the manufacturer’s approved product labelling. Refer to the product packaging or package insert for the applicable storage conditions.

Frequently Asked Questions

1. What is Cefoperazone & Sulbactam for Injection used for?

It is a combination antibiotic formulation used for selected bacterial infections caused by susceptible organisms, according to approved prescribing information.

2. What does the 2:1 ratio mean?

The 2:1 designation indicates the stated component ratio of cefoperazone to sulbactam. Confirm the exact component quantities for each listed strength against the approved product specification.

3. What strengths are listed for this product?

The supplied strengths are 750mg, 1.5gm and 3gm.

4. Can this injection treat viral infections?

No. Antibiotics treat susceptible bacterial infections and do not treat viral illnesses such as influenza or the common cold.

5. Who should administer this injection?

Qualified healthcare personnel should prepare and administer it according to the approved product instructions.

6. What side effects may occur?

Possible effects include gastrointestinal symptoms, rash and injection-site discomfort. Severe allergic reactions, significant bleeding or severe diarrhoea require prompt medical attention.

7. How should the product be stored?

Follow the storage conditions specified in the approved product labelling and package insert.